Fosun Pharma Announces 2026 Interim Results
- Written by PR Newswire
Globalization Accelerates Value Realization of Innovative Drugs
SHANGHAI, Aug. 25, 2026 /PRNewswire/ -- On August 25, Fosun Pharma ("the Company", stock code: 600196.SH; 02196.HK) announced its interim results for 2026. In the first half of 2026 ("the Reporting Period", or 1H2026), the Company recorded revenue of...













